Keith Goldan

Keith Goldan

Director of Finance/CFO at SYNDAX PHARMACEUTICALS, INC.

Net worth: 3 M $ as of 2026-05-30

54 year
Health Technology
Consumer Services
Commercial Services

Profile

Keith Alan Goldan is the founder of Century Capital Associates.
Currently, Mr. Goldan is an Independent Director at Abeona Therapeutics, Inc. since 2026 and Chief Financial Officer at Syndax Pharmaceuticals, Inc. since 2022.
Formerly, Mr. Goldan was Chief Financial Officer & Director at Realm Therapeutics Plc from 2004 to 2008, CFO, Treasurer & Senior Vice President at Fibrocell Science, Inc. from 2015 to 2017, Chief Financial Officer at OptiNose, Inc. from 2017 to 2022, Chief Financial Officer at Cantel Medical (UK) Ltd., CFO, Vice President & Head-Investor Relations at NuPathe, Inc. from 2012 to 2013, and Chief Financial Officer & Vice President at Biosyn, Inc. Education includes undergraduate studies at Robert H.
Smith School of Business and an MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-31 139,252 ( 0.16% ) 3 M $ 2026-05-30
2026-04-14 32,751 ( 0.06% ) 189 301 $ 2026-05-30

Keith Goldan active positions

CompaniesPositionStart
SYNDAX PHARMACEUTICALS, INC. Director of Finance/CFO 2022-06-12
ABEONA THERAPEUTICS INC. Director/Board Member 2026-03-31

Former positions of Keith Goldan

CompaniesPositionEnd
OPTINOSE, INC. Director of Finance/CFO 2022-06-09
FIBROCELL SCIENCE, INC. Director of Finance/CFO 2016-12-31
Director of Finance/CFO 2008-10-30
REALM THERAPEUTICS PLC Director of Finance/CFO 2008-10-12
Founder -
See the detail of Keith Goldan's experience

Training of Keith Goldan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

31

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Consumer Services

Consumer Services